Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | WT2725 |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
WT2725 is a oligopeptide vaccine that induces WT1-specific cytotoxic T-lymphocytes, potentially resulting in antitumor activity against WT1-positive tumors (Journal of Clinical Oncology 35, no. 15_suppl (May 20 2017) 2066-2066). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C102751 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| WT2725 | WT2725 | 0 | 1 |